Literature DB >> 24806164

Taming the transplantation troll by targeting terminase.

Paul D Griffiths1, Vincent C Emery.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24806164     DOI： 10.1056/NEJMe1401567

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands.

Authors:  Jennifer T Miller; Haiyan Zhao; Takashi Masaoka; Brittany Varnado; Elena M Cornejo Castro; Vickie A Marshall; Kaivon Kouhestani; Anna Y Lynn; Keith E Aron; Anqi Xia; John A Beutler; Danielle R Hirsch; Liang Tang; Denise Whitby; Ryan P Murelli; Stuart F J Le Grice
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

2.  How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.

Authors:  Firas El Chaer; Dimpy P Shah; Roy F Chemaly
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

3.  In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication.

Authors:  Steffen Wildum; Holger Zimmermann; Peter Lischka
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

4.  Bone marrow transplantation alters lung antigen-presenting cells to promote TH17 response and the development of pneumonitis and fibrosis following gammaherpesvirus infection.

Authors:  X Zhou; H Loomis-King; S J Gurczynski; C A Wilke; K E Konopka; C Ptaschinski; S M Coomes; Y Iwakura; L F van Dyk; N W Lukacs; B B Moore
Journal:  Mucosal Immunol       Date:  2015-09-16       Impact factor: 7.313

Review 5.  The human cytomegalovirus terminase complex as an antiviral target: a close-up view.

Authors:  G Ligat; R Cazal; S Hantz; S Alain
Journal:  FEMS Microbiol Rev       Date:  2018-03-01       Impact factor: 16.408

6.  Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV).

Authors:  Sameera Senaweera; Tiffany C Edwards; Jayakanth Kankanala; Yan Wang; Rajkumar Lalji Sahani; Jiashu Xie; Robert J Geraghty; Zhengqiang Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-23       Impact factor: 14.903

Review 7.  Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus.

Authors:  Dante P Melendez; Raymund R Razonable
Journal:  Infect Drug Resist       Date:  2015-08-05       Impact factor: 4.003
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.